Lucid Diagnostics, Inc. (LUCD)
0.411
+0.08
(+25.42%)
USD |
NASDAQ |
Oct 23, 16:00
0.4029
-0.01
(-1.97%)
After-Hours: 20:00
Lucid Diagnostics Enterprise Value : 69.91M for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 69.91M |
| October 22, 2026 | 54.02M |
| October 21, 2026 | 55.10M |
| October 20, 2026 | 58.63M |
| October 19, 2026 | 63.50M |
| October 16, 2026 | 82.69M |
| October 15, 2026 | 90.72M |
| October 14, 2026 | 95.11M |
| October 13, 2026 | 107.10M |
| October 12, 2026 | 105.46M |
| October 09, 2026 | 113.21M |
| October 08, 2026 | 115.52M |
| October 07, 2026 | 110.44M |
| October 06, 2026 | 105.96M |
| October 05, 2026 | 104.68M |
| October 02, 2026 | 111.17M |
| October 01, 2026 | 112.60M |
| September 30, 2026 | 134.76M |
| September 29, 2026 | 145.83M |
| September 28, 2026 | 145.20M |
| September 25, 2026 | 149.07M |
| September 24, 2026 | 151.36M |
| September 23, 2026 | 151.53M |
| September 22, 2026 | 161.77M |
| September 21, 2026 | 152.71M |
| Date | Value |
|---|---|
| September 18, 2026 | 141.38M |
| September 17, 2026 | 140.37M |
| September 16, 2026 | 151.05M |
| September 15, 2026 | 142.89M |
| September 14, 2026 | 140.79M |
| September 11, 2026 | 140.85M |
| September 10, 2026 | 144.89M |
| September 09, 2026 | 148.14M |
| September 08, 2026 | 162.58M |
| September 04, 2026 | 170.72M |
| September 03, 2026 | 172.95M |
| September 02, 2026 | 180.34M |
| September 01, 2026 | 177.32M |
| August 31, 2026 | 178.18M |
| August 28, 2026 | 180.62M |
| August 27, 2026 | 179.21M |
| August 26, 2026 | 176.67M |
| August 25, 2026 | 184.17M |
| August 24, 2026 | 182.26M |
| August 21, 2026 | 175.45M |
| August 20, 2026 | 174.71M |
| August 19, 2026 | 184.17M |
| August 18, 2026 | 180.26M |
| August 17, 2026 | 178.01M |
| August 14, 2026 | 176.10M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| PAVmed, Inc. | 15.00M |
| Alphatec Holdings, Inc. | 2.205B |
| Electromed, Inc. | 200.30M |
| Pulse Biosciences, Inc. | 3.659B |
| Abbott Laboratories | 207.10B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -11.69M |
| Revenue (Quarterly) | 1.474M |
| Total Expenses (Quarterly) | 13.16M |
| EPS Diluted (Quarterly) | -0.0804 |
| Gross Profit Margin (Quarterly) | -13.23% |
| Profit Margin (Quarterly) | -792.9% |
| Earnings Yield | -114.2% |
| Normalized Earnings Yield | -111.80 |